← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-ALOfficial filing linked
Tommy Tuberville disclosed SELL $AAPL
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$50K – $100K
Filed
2026-01-15
Trade date
2025-12-17
Disclosure lag
29 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 29 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $50K – $100K, which is the public reporting band rather than an exact profit or loss figure.
419 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Tommy Tuberville, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 26 lobbying filings.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID b2bdf363-af39-43c8-ae93-13ed14aa3752 · filed 2026-01-15 · disclosed 29d after transaction
Market context
Apple Inc.
Sector: Technology
Vs SPY: -5.4%
Factual flags
- 26 lobbying filings linked to this ticker.
- 19 nearby same-ticker disclosures in the surrounding 30-day window.
- Traded AAPL 23d before lobbying filing by WILMERHALE ON BEHALF OF APPLE INC. ($110,000) (committee overlap: Healthcare)
- 11 trades filed on 2026-01-15 (batch dump)
- 3 members traded AAPL within 7 days (starting 2025-12-16)
- Trade upper bound: $100,000
Member trail
Tommy Tuberville
U.S. Senate · AL
Senate Committee on AgricultureNutritionand ForestrySenate Committee on Armed ServicesSenate Committee on HealthEducation
Ticker trail
$AAPL
Apple Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.